Inhibiting glutaminase (GLS1) can reduce bleomycin-induced pulmonary fibrosis, indicating that regulating the glutamine metabolism pathway may have therapeutic potential for pulmonary fibrosis25. Here, GLS is linked to pulmonary fibrosis.